4//SEC Filing
Ovid Therapeutics Inc. 4
Accession 0001209191-17-031374
$OVIDCIK 0001636651operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:14 PM ET
Size
9.8 KB
Accession
0001209191-17-031374
Insider Transaction Report
Form 4
During Matthew
DirectorPresident and CSO10% Owner
Transactions
- Conversion
Series A Preferred Stock
2017-05-10−28,245→ 0 total→ Common Stock (28,245 underlying) - Conversion
Common Stock
2017-05-10+28,245→ 4,307,314 total
Holdings
- 93,023(indirect: By Trust)
Common Stock
- 93,023(indirect: By Trust)
Common Stock
- 93,023(indirect: By Trust)
Common Stock
- 93,023(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001636651
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:14 PM ET
- Size
- 9.8 KB